Douglas Tsao
Stock Analyst at HC Wainwright & Co.
(3.96)
# 625
Out of 5,043 analysts
488
Total ratings
48.65%
Success rate
11.42%
Average return
Main Sectors:
Stocks Rated by Douglas Tsao
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Maintains: Buy | $115 → $232 | $185.94 | +24.77% | 26 | Oct 16, 2025 | |
| CABA Cabaletta Bio | Reiterates: Buy | $16 | $2.79 | +473.48% | 27 | Oct 10, 2025 | |
| PTGX Protagonist Therapeutics | Reiterates: Buy | $80 | $75.25 | +6.31% | 35 | Oct 8, 2025 | |
| OTLK Outlook Therapeutics | Reiterates: Neutral | $1 | $1.34 | -25.37% | 18 | Sep 30, 2025 | |
| ROIV Roivant Sciences | Maintains: Buy | $18 → $20 | $18.81 | +6.33% | 21 | Sep 18, 2025 | |
| ALKS Alkermes | Reiterates: Neutral | $46 | $29.72 | +54.78% | 25 | Sep 9, 2025 | |
| RAPP Rapport Therapeutics | Maintains: Buy | $31 → $34 | $26.48 | +28.40% | 2 | Sep 8, 2025 | |
| IMVT Immunovant | Reiterates: Buy | $35 | $21.43 | +63.32% | 23 | Sep 4, 2025 | |
| RZLT Rezolute | Reiterates: Buy | $14 | $9.45 | +48.15% | 18 | Sep 3, 2025 | |
| EVO Evotec SE | Maintains: Buy | $8 → $7 | $4.12 | +69.90% | 10 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $30 | $17.39 | +72.51% | 15 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $20 | $7.22 | +177.01% | 28 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $720 → $774 | $829.83 | -6.73% | 40 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $118 | $89.65 | +31.62% | 16 | Jul 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $81 | $44.34 | +82.68% | 24 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $53 | $41.89 | +26.52% | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.60 | +337.50% | 25 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $22.54 | +50.84% | 16 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $19.64 | -3.26% | 4 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $2.03 | +491.13% | 17 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $2.69 | +569.14% | 7 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $29.78 | +91.40% | 26 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $14.30 | +4.90% | 15 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $5 | $4.53 | +10.38% | 14 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $0.91 | +39,460.44% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 | $1.31 | +663.36% | 5 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $168 → $182 | $182.03 | -0.02% | 4 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $19 | $8.02 | +133.79% | 2 | Jan 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $25 → $18 | $41.70 | -56.83% | 3 | Aug 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $8 | $19.61 | -59.20% | 7 | Jun 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $52 | $21.33 | +143.79% | 2 | Jun 11, 2019 |
Praxis Precision Medicines
Oct 16, 2025
Maintains: Buy
Price Target: $115 → $232
Current: $185.94
Upside: +24.77%
Cabaletta Bio
Oct 10, 2025
Reiterates: Buy
Price Target: $16
Current: $2.79
Upside: +473.48%
Protagonist Therapeutics
Oct 8, 2025
Reiterates: Buy
Price Target: $80
Current: $75.25
Upside: +6.31%
Outlook Therapeutics
Sep 30, 2025
Reiterates: Neutral
Price Target: $1
Current: $1.34
Upside: -25.37%
Roivant Sciences
Sep 18, 2025
Maintains: Buy
Price Target: $18 → $20
Current: $18.81
Upside: +6.33%
Alkermes
Sep 9, 2025
Reiterates: Neutral
Price Target: $46
Current: $29.72
Upside: +54.78%
Rapport Therapeutics
Sep 8, 2025
Maintains: Buy
Price Target: $31 → $34
Current: $26.48
Upside: +28.40%
Immunovant
Sep 4, 2025
Reiterates: Buy
Price Target: $35
Current: $21.43
Upside: +63.32%
Rezolute
Sep 3, 2025
Reiterates: Buy
Price Target: $14
Current: $9.45
Upside: +48.15%
Evotec SE
Aug 14, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $4.12
Upside: +69.90%
Aug 12, 2025
Maintains: Buy
Price Target: $54 → $30
Current: $17.39
Upside: +72.51%
Aug 6, 2025
Maintains: Buy
Price Target: $27 → $20
Current: $7.22
Upside: +177.01%
Aug 1, 2025
Maintains: Buy
Price Target: $720 → $774
Current: $829.83
Upside: -6.73%
Jul 3, 2025
Reiterates: Buy
Price Target: $118
Current: $89.65
Upside: +31.62%
Jun 27, 2025
Reiterates: Buy
Price Target: $81
Current: $44.34
Upside: +82.68%
May 13, 2025
Reiterates: Buy
Price Target: $53
Current: $41.89
Upside: +26.52%
Apr 29, 2025
Reiterates: Buy
Price Target: $7
Current: $1.60
Upside: +337.50%
Apr 23, 2025
Reiterates: Buy
Price Target: $34
Current: $22.54
Upside: +50.84%
Apr 3, 2025
Reiterates: Buy
Price Target: $19
Current: $19.64
Upside: -3.26%
Apr 1, 2025
Reiterates: Buy
Price Target: $12
Current: $2.03
Upside: +491.13%
Mar 7, 2025
Reiterates: Buy
Price Target: $18
Current: $2.69
Upside: +569.14%
Mar 3, 2025
Reiterates: Buy
Price Target: $57
Current: $29.78
Upside: +91.40%
Feb 27, 2025
Reiterates: Buy
Price Target: $15
Current: $14.30
Upside: +4.90%
Feb 26, 2025
Reiterates: Neutral
Price Target: $5
Current: $4.53
Upside: +10.38%
Oct 1, 2024
Reiterates: Buy
Price Target: $360
Current: $0.91
Upside: +39,460.44%
Jun 7, 2022
Downgrades: Neutral
Price Target: $10
Current: $1.31
Upside: +663.36%
Feb 20, 2020
Maintains: Equal-Weight
Price Target: $168 → $182
Current: $182.03
Upside: -0.02%
Jan 23, 2020
Downgrades: Neutral
Price Target: $19
Current: $8.02
Upside: +133.79%
Aug 29, 2019
Maintains: Underweight
Price Target: $25 → $18
Current: $41.70
Upside: -56.83%
Jun 11, 2019
Initiates: Underweight
Price Target: $8
Current: $19.61
Upside: -59.20%
Jun 11, 2019
Initiates: Overweight
Price Target: $52
Current: $21.33
Upside: +143.79%